- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Zhejiang Hospital
Total 100319 results
-
Zhejiang Cancer HospitalCompleted
-
Zhejiang Cancer HospitalActive, not recruitingGastric Cancer | Diagnosis | Multi-omicsChina
-
Zhejiang Cancer HospitalActive, not recruiting
-
Zhejiang Cancer HospitalCompleted
-
Zhejiang Cancer HospitalActive, not recruitingGastric Cancer | Signet Ring Cell CarcinomaChina
-
Zhejiang Cancer HospitalCompletedEndobronchial Metastases | Bronchoesophageal Fistula | General Anesthetic Drug Adverse ReactionChina
-
Zhejiang Cancer HospitalCompletedBreast Cancer | HER2 | Preoperative Systemic Treatment
-
Zhejiang Cancer HospitalUnknownCarcinoma, Hepatocellular
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownCervical CancerChina
-
Zhejiang Cancer HospitalUnknownPeripheral T Cell LymphomaChina
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Diseases | Neoplasm, BreastChina
-
Zhejiang Cancer HospitalUnknownRectal Neoplasms | Neoadjuvant Therapy | Circulating Tumor DNAChina
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Neoplasms | Breast Diseases
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalCompletedSafety Issues | Effect of DrugsChina
-
Zhejiang Cancer HospitalUnknownNasopharyngeal CarcinomaChina
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownNasopharyngeal CarcinomaChina
-
Zhejiang Cancer HospitalUnknownNasopharyngeal CarcinomaChina
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownDrug Safety | Surgically-Created Resection CavityChina
-
Zhejiang Cancer HospitalCompleted
-
Zhejiang Cancer HospitalCompletedEsophageal CancerChina
-
Zhejiang Cancer HospitalCompletedUltrasonography | Lipemia | Endometrium | Mammography | EstrogenChina
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung CancerChina
-
Zhujiang HospitalNot yet recruitingRecurrence | Hepatocellular Carcinoma | Surgery | Circulating Tumor CellChina
-
Zhujiang HospitalNot yet recruitingEfficacy Endpoint: no New Cerebrovascular Adverse Events Within 1 Year | Safety Endpoint: no New Moderate or Serious Adverse Events Within 1 Year | All-cause Mortality Events (Within 1 Year) | Incident Ischemic Stroke Events (Within 1 Year) | New Hemorrhagic Stroke Events (Within 1 Year) | New... and other conditions
-
Zhujiang HospitalRecruiting
-
Zhujiang HospitalRecruitingHigh Grade Glioma | Radiation Toxicity | Overall Survival | Progression-free Survival | MRI Simulated PositioningChina
-
Zhujiang HospitalRecruiting
-
Zhujiang HospitalRecruitingHuman Microecology;Colorectal Disease;Auxiliary DiagnosisChina
-
Zhujiang HospitalRecruitingHepatocellular Carcinoma ResectableChina
-
Zhujiang HospitalRecruitingCOVID-19 Pneumonia | Vitamin CChina
-
Zhujiang HospitalRecruitingOrthotopic NeobladderChina
-
Zhujiang HospitalRecruitingLeukemia, Myeloid, AcuteChina
-
Zhujiang HospitalRecruitingHealthy | Feces | Breast-milk CollectionChina
-
Zhujiang HospitalRecruiting
-
Zhujiang HospitalRecruiting
-
Zhujiang HospitalRecruiting
-
Zhujiang HospitalRecruiting
-
Zhujiang HospitalRecruitingChronic Airway DiseaseChina
-
Zhujiang HospitalRecruiting
-
Zhujiang HospitalCompleted
-
Zhujiang HospitalCompleted
-
Zhujiang HospitalWithdrawn
-
Zhujiang HospitalCompleted
-
Zhujiang HospitalCompleted